High pressure promotes alpha-synuclein aggregation in cultured neuronal cells
Urszula Golebiewska1, Suzanne Scarlata2
1Dept. of Biological Sciences and Geology, Queensborough Community College, Bayside, NY 11364, USA.
FEBS Letters
|October 6, 2015
Summary
Hydrostatic pressure increases alpha-synuclein aggregation in neurons, potentially contributing to neurodegenerative diseases like Parkinson's. This pressure also disrupts protein interactions, promoting further aggregation.
Area of Science:
- Neuroscience
- Biochemistry
- Cell Biology
Background:
- Alpha-synuclein aggregation into plaques is a hallmark of Parkinson's disease and other neurodegenerative disorders.
- Oligomerization of alpha-synuclein is believed to initiate the formation of these pathological plaques.
Purpose of the Study:
- To investigate the impact of hydrostatic pressure on alpha-synuclein aggregation within cultured neuronal cells.
- To determine if pressure-induced aggregation affects alpha-synuclein's interaction with binding partners like phospholipase C beta (PLCβ).
Main Methods:
- Utilized cultured neuronal cells to study alpha-synuclein aggregation under varying hydrostatic pressure conditions.
- Assessed the levels of monomeric and aggregated alpha-synuclein in response to pressure.
- Quantified the interaction between alpha-synuclein and phospholipase C beta 1 (PLCβ1) under different pressure levels.
Main Results:
- Hydrostatic pressure induced a transition of alpha-synuclein from monomeric forms to higher-order aggregates.
- Increased pressure led to a reduction in both PLCβ1 levels and the formation of alpha-synuclein/PLCβ1 complexes.
- Pressure appears to promote the dissociation of alpha-synuclein from its protein partners.
Conclusions:
- Hydrostatic pressure is a significant factor in promoting alpha-synuclein oligomerization.
- The release of binding partners like PLCβ1, induced by pressure, may facilitate alpha-synuclein aggregation.
- These findings offer new insights into the mechanisms driving neurodegeneration and potential therapeutic targets.
Related Concept Videos
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
03:03Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...